We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

HAEMONETICS

Haemonetics Corporation’s comprehensive portfolio of devices, information management, and consulting services offers ... read more Featured Products: More products

Download Mobile App




Haemonetics Displays Small, Cartridge-Based TEG 6s Hemostasis Analyzer at AACC Clinical Lab Expo

By LabMedica International staff writers
Posted on 29 Sep 2021

Haemonetics Corporation (Boston, MA, USA) displayed its small, cartridge-based TEG 6s hemostasis analyzer at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo, the world’s premier gathering of clinical lab professionals from around the world. More...

Haemonetics provides blood management solutions to help improve care & reduce costs. The company’s TEG 6s system addresses the limitations of traditional testing by delivering fast, comprehensive, & functional assessment of coagulation. The analyzer’s easy-to-use test cartridge delivers a rapid, comprehensive picture of patient hemostasis giving invaluable insight. With a small footprint, robust quality control processes, vibration resistance, and simple, automated cartridge the TEG 6s can be readily deployed in varied settings.

Alongside the TEG 6s hemostasis analyzer, Haemonetics also demonstrated the TEG Manager software that allows secure, real time remote access to patient results, analyzer/user admin & LIS/POC system connectivity. The TEG Manager software system delivers convenient, secure TEG analyzer results viewing and system administration. It provides for robust TEG analyzer data warehousing, real-time, on-demand remote patient results viewing, clinical report generation, LIS connectivity, and user/device management/reporting. The Interpretation Guidance module allows clinicians the option to customize clinical alert messages according to your institution’s guidelines. It displays active and historical TEG results wherever/whenever within the hospital network. It also provides administrative functions including dashboard views of the status of all TEG analyzers throughout the hospital, manage users/access, and a robust suite of operational and audit reporting.

Related Links:
Haemonetics Corporation 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Portable POCT Blood Gas Analyzer
BD100
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The AidaBREAST assay integrates multimodal data to provide patient-specific 10-year recurrence risk and individualized predictions of radiation therapy benefit (photo courtesy of PreludeDx)

Validated Test Predicts Recurrence Risk and Radiation Benefit in Early-Stage Breast Cancer

For women with early-stage invasive breast cancer who undergo breast-conserving surgery, clinicians must assess both the risk of locoregional recurrence and the potential benefit of adjuvant radiation therapy.... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: Natera\'s MCED assay analyzes cell-free DNA in blood to screen for multiple cancers (Image Credit: Adobe Stock)

Multi-Cancer Screening Blood Test Gains FDA Breakthrough Designation

Natera Inc.’s (Austin, TX, USA) multi-cancer early detection (MCED) assay has received Breakthrough Device designation (BDD) from the U.S. Food and Drug Administration (FDA). The assay analyzes cell-free... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.